State Of Wisconsin Investment Board Cor Medix Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.22 - $4.61 $102,074 - $146,137	-31,700 Reduced 52.0%	29,263 $121,000
Q4 2022 Feb 14, 2023	SELL	$2.81 - $4.45 $70,250 - $111,250	-25,000 Reduced 29.08%	60,963 $257,000
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $181,430 - $483,814	-64,337 Reduced 42.81%	85,963 $243,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $214,305 - $440,385	78,500 Added 109.33%	150,300 $604,000
Q1 2022 May 13, 2022	BUY	$3.83 - $6.24 $62,046 - $101,088	16,200 Added 29.14%	71,800 $393,000
Q4 2021 Feb 11, 2022	BUY	$4.47 - $5.56 $14,751 - $18,348	3,300 Added 6.31%	55,600 $253,000
Q3 2021 Nov 12, 2021	BUY	$4.46 - $7.11 $114,622 - $182,727	25,700 Added 96.62%	52,300 $243,000
Q2 2021 Aug 12, 2021	BUY	$6.05 - $10.09 $160,930 - $268,394	26,600 New	26,600 $182,000
Q1 2020 May 06, 2020	SELL	$2.35 - $7.08 $83,190 - $250,632	-35,400 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$6.38 - $9.69 $225,852 - $343,026	35,400 New	35,400 $226,000

118

17.9M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $419M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.